http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#Head
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#assertion
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#provenance
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#pubinfo
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#assertion
http://purl.obolibrary.org/obo/MONDO_0002046
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/MONDO_0002046
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://go.drugbank.com/drugs/DB09072
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association
http://www.w3.org/2000/01/rdf-schema#label
nly a few medications are available for the treatment of alcohol use disorders (AUDs). Areas covered: This paper discusses approved AUD medications, including the opioid antagonists naltrexone and nalmefene (the latter is licensed for reduction of alcohol consumption only), the putative glutamate receptor antagonist acamprosate and the aldehyde dehydrogenase inhibitor disulfiram. It also covers off-label medications of interest, including topiramate, gabapentin, ondansetron, varenicline, baclofen, sodium oxybate and antidepressants.
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association
https://w3id.org/biolink/vocab/publications
https://pubmed.ncbi.nlm.nih.gov/28658981/
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/OffLabelIndication
https://go.drugbank.com/drugs/DB09072
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#provenance
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#pubinfo
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#sig
http://purl.org/nanopub/x/hasSignature
jeLBHsuUvsMdpK+yTeiGKnslFJ62Ok6aU3Avzs5TWiBSIJBTfQU3i36iUTypz+QhygVSY8gbi8jrFxhutgZ+1KE37rxxXx90C3Ki9covQ+CsI37DVncFf6YcjmWD52sYMSXjA8PLS50qYyoXVoYSwLoh09vMVyaywf+xa6pYF2g=
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
http://purl.org/dc/terms/created
2021-08-25T19:58:40.391+02:00
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
http://purl.org/nanopub/x/supersedes
http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAjpBMlw3owYhJUBo3DtsuDlXsNAJ8cnGeWAutDVjuAuI
http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAZdZj78B6nKrP1Q00oFzsK07u7WdiY3sToz-H-H2nSgg